PRLog - Aug. 4, 2011 - NEEDHAM, Mass. -- NEEDHAM, MASS. – Cambridge Healthtech Institute’s Insight Pharma Reports announces the Next-Generation Mass Spectrometry:
Advances in biomedical instrumentation are enabling a new perspective that could not have been achieved even a decade ago. Mass spectrometry is the most significant and far reaching of these developments, allowing the generation of data in the medical sciences that brings new insights into critical questions. This report analyzes:
• Physical principles and analytical applications of mass spectrometry
•The role of mass spectrometry in genomics, proteomics, metabolomics, and lipidomics
•Advances in mass spectrometry instrumentation and methods
•Current and emerging applications of mass spectrometry
•Future prospects for the mass spectrometry industry
Mass spectrometry is a highly sophisticated instrumentation technology that has emerged as the premier method for the analytical definition of biomolecules. This newly defined role has been the result of significant improvements in these instruments, combined with the introduction of a number of new approaches to preparation and separation of the target molecules.
Next-Generation Mass Spectrometry:
We briefly review the history of mass spectrometry and consider (in a non-mathematical framework) the underlying physical principles that dictate the construction and limitations of mass spectrometers. Today mass spectrometry is characterized by rapid advances in technology, driven by manufacturers’
In reviewing mass spectrometry instrumentation, Next-Generation Mass Spectrometry:
Finally, we draw conclusions about the industry’s future prospects. Mass spectrometry, as the leading technology for the characterization of macromolecules, is likely in the coming years to produce breakthrough advances in the diagnosis and understanding of a host of recalcitrant diseases.
For more information and to purchase this Insight Pharma Report, visit: http://www.insightpharmareports.com
About Insight Pharma Reports
Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace. Insight Pharma Reports is a division within Cambridge Healthtech Institute. http://insightpharmareports.com
# # #
Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets.